Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood. - Wikidata - wikimedia - TriplyDB

Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.

Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.

http://www.wikidata.org/entity/Q36076282

about

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases A Partially Purified Acinetobacter baumannii Phage Preparation Exhibits no Cytotoxicity in 3T3 Mouse Fibroblast Cells.Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy.Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.A bacteriophages journey through the human body.Phages and immunomodulation.Antiphage activity of sera during phage therapy in relation to its outcome.Delivering phage therapy per os: benefits and barriers.Ménage à trois in the human gut: interactions between host, bacteria and phages.Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages.Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome.Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles.Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.Metals Enhance the Killing of Bacteria by Bacteriophage in Human Blood.Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies.In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity.Beyond Bacteria: Bacteriophage-Eukaryotic Host Interactions Reveal Emerging Paradigms of Health and Disease.Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

P2860

Q26740597-5CE930E2-C78E-4542-BEE8-3720767C07E8 Q28069939-26E2CF38-1C97-47F1-A9B0-063ECFDDC9FE Q36106493-1E605A8E-F30F-4B0E-9794-6374D08D6782 Q37360042-6A601D48-2A9B-4181-8CA7-8C1DDEFA0466 Q37716726-713316AB-2084-4B39-8BBF-37E6F61C21C9 Q38556802-9950654C-98FC-4A4A-B3A8-60BAC7CDCD18 Q38691927-8A244094-12CF-4CFA-95A7-45193538FAC1 Q38819873-BA168A74-D76D-4433-83D9-DF3864738188 Q39019401-1C359684-6681-4B5A-B0C0-4570CE3C851B Q39276552-302D0F01-2C5D-4BC1-B050-849BCFD80EEB Q39700208-57E1AE46-E07E-43EF-8E6C-92A106164500 Q40093280-4F52319C-DDA0-4B0F-8E4D-3642B8E64783 Q40119098-B81D9841-1819-4C4A-8C41-B101C8142D8B Q40604790-0F440966-93BE-4DAF-878A-7FB134057A4E Q44666946-1B2E5293-BA31-48F2-975B-1A426FDCDCB6 Q46201519-688A0661-210E-4CE6-8DB6-B59716193EBD Q49297714-1BBC1F13-A936-4207-82DE-83159B71DAA1 Q50100593-3DD835C3-9A84-46C9-A229-62AC305F5098 Q53699945-C903F79A-68A5-4490-9FC6-F770EB55FCAA Q54249868-C2C4ADD0-DB9E-42B4-AFB1-5ABD60869F05 Q55531891-7E8AF5AD-13C8-4FA4-B8B1-5B6FAF0D4249 Q57940652-E08A5401-51D7-4227-B9D8-5815A7EC519A

P2860

Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.

http://www.wikidata.org/entity/Q36076282

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@ast

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@en

type

label

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@ast

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@en

prefLabel

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@ast

Oral Application of T4 Phage I ...... n in the Gut and in the Blood.

@en

P1433

Q36076282-BEE22008-713E-4BAA-A8BC-482C4305FFF9

P1476

Q36076282-8F66A2AA-27F6-443A-B762-D784F92E4042

P2093

Q36076282-0C2DBAB9-FC4A-4063-AA39-92E526C2DE79

Q36076282-217AC128-4A7A-4CE3-9BA1-9CFD9FF9DFCC

Q36076282-38ED7D8F-8508-460F-B2BB-6B5EF0E8B2EB

Q36076282-3F3726E0-16F0-4B3F-A946-427EF6C9CE85

Q36076282-49870E5F-8B94-4CB5-9B1A-93EAE7D38F92

Q36076282-6AB2A03C-821A-4B15-8B0B-D5C69A73349F

Q36076282-A0DE08B0-D36B-42CA-8425-AD22C913D921

Q36076282-AA7D902C-6B29-40EE-9D62-21863F839B16

Q36076282-BF4CC1C6-BD13-4CC4-8189-9988CA129820

Q36076282-D33E8A2A-86A9-4F69-A176-2E97FEDFD5EF

P2860

Q36076282-1225AF94-6434-4A9B-A8EB-E99C430A109D

Q36076282-12C304D3-70CB-4719-879C-8287CCC4C17F

Q36076282-1A285706-FBCA-40D6-88CE-BF07175CB6EA

Q36076282-1B3EFAED-CE17-4E15-851D-F00DC341C62B

Q36076282-29AAAB7A-F4F4-42EC-B65B-21A1752B2346

Q36076282-31BB8131-7DAF-42F0-AE5D-FC1E575D80EE

Q36076282-33105181-4C9B-4E7B-B303-0BE9279D7864

Q36076282-35805AF5-3290-442B-8902-6BDE8322F2A0

Q36076282-37BB684E-7004-4535-9918-11CA608A4868

Q36076282-395077EC-FCD0-40C7-9DFD-151FBEAB1856

P304

Q36076282-512CE174-7AB4-46F5-86E8-161A0F0F89B7

P31

Q36076282-F77D5FE6-2826-40BB-93B1-5687CC0A8836

P356

Q36076282-088CAB13-30A0-48BD-B510-41205DBEBBEA

P433

Q36076282-A599B26C-F057-48DE-AFE8-15CA57F5376A

P478

Q36076282-FC34288D-D4A0-4FB4-B526-69864C1CD16C

P50

Q36076282-4AEF5227-9027-4DF0-8359-6FDF561FBE4F

Q36076282-A4C2DEAB-17D1-44EA-ADF9-FD6E9B61534F

P577

Q36076282-1868CFA7-C757-41B5-8289-395BCB80AF0C

P5875

Q36076282-51DEFD8C-9AC1-418C-B84A-5412D6E27248

P698

Q36076282-E9B6E693-6C49-4BDE-A835-C5C892180EE9

P932

Q36076282-C1AEDC89-5873-4F2A-ADAE-B6BB4B400170

P356

P1433

P1476

Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood

@en

P2093

Agnieszka Kopciuch

http://www.w3.org/2001/XMLSchema#string

Agnieszka Piotrowicz

http://www.w3.org/2001/XMLSchema#string

Anna Kłopot

http://www.w3.org/2001/XMLSchema#string

Barbara Owczarek

http://www.w3.org/2001/XMLSchema#string

Dorota Lecion

http://www.w3.org/2001/XMLSchema#string

Jarosław Ciekot

http://www.w3.org/2001/XMLSchema#string

Joanna Majewska

http://www.w3.org/2001/XMLSchema#string

Karolina Wojtyna

http://www.w3.org/2001/XMLSchema#string

Katarzyna Hodyra-Stefaniak

http://www.w3.org/2001/XMLSchema#string

Krystyna Dąbrowska

http://www.w3.org/2001/XMLSchema#string

P2860

Phage Therapy in Clinical Practice: Treatment of Human Infections

Bacteriophage therapy

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.

Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.

Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus

Phage neutralization by sera of patients receiving phage therapy

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.

P304

4783-4799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V7082845

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Paulina Miernikiewicz

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281447924

http://www.w3.org/2001/XMLSchema#string

P698

26308042

http://www.w3.org/2001/XMLSchema#string

P932

4576206

http://www.w3.org/2001/XMLSchema#string